P Dlouhý, C Mucha, L Mokrá, M Kuhn… - Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Background/Objectives: Molnupiravir (MOV), an oral antiviral COVID-19 treatment, was
introduced in the Czech Republic in December 2021 for COVID-19 patients at a high risk of …